Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -297,409 | -190,755 | -91,576 | -626,604 | -470,812 |
| Depreciation Amortization | 59,843 | 56,179 | 51,994 | 454,063 | 375,170 |
| Income taxes - deferred | -2 | 1 | -1 | -46,930 | -50,909 |
| Accounts receivable | -39,029 | -31,310 | -39,500 | -1,539 | -9,887 |
| Other Working Capital | 64,164 | 54,332 | 65,510 | -4,003 | 78,607 |
| Other Operating Activity | 134,749 | 110,861 | 84,334 | 66,595 | 19,701 |
| Operating Cash Flow | $-77,684 | $-692 | $70,761 | $-158,418 | $-58,130 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -193,834 | -151,917 | -50,581 | -17,720 | 9,838 |
| PPE Investments | 25,321 | 25,825 | -9,588 | -28,438 | -22,872 |
| Net Acquisitions | N/A | -54,763 | N/A | -92,181 | N/A |
| Purchase Of Investment | 10,000 | N/A | N/A | -38,398 | N/A |
| Purchase Sale Intangibles | -65,017 | N/A | -54,763 | N/A | -69,285 |
| Other Investing Activity | -65,017 | 0 | -54,763 | 0 | -69,285 |
| Investing Cash Flow | $-223,530 | $-180,855 | $-114,932 | $-176,737 | $-82,319 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 241,792 | 241,792 | N/A | N/A | N/A |
| Debt Repayment | -19,690 | -1,490 | -1,490 | -301,379 | -1,379 |
| Common Stock Issued | 7,293 | 6,720 | 2,030 | 29,994 | 27,576 |
| Other Financing Activity | 0 | 0 | 0 | 917,785 | -282 |
| Financing Cash Flow | $229,395 | $247,022 | $540 | $646,400 | $25,915 |
| Exchange Rate Effect | 1,325 | -7,217 | -2,030 | 3,114 | 19 |
| Beginning Cash Position | 610,284 | 610,284 | 610,284 | 295,925 | 295,925 |
| End Cash Position | 539,790 | 668,542 | 564,623 | 610,284 | 181,410 |
| Net Cash Flow | $-70,494 | $58,258 | $-45,661 | $314,359 | $-114,515 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,684 | -692 | 70,761 | -158,418 | -58,130 |
| Capital Expenditure | -2,735 | -2,213 | -9,588 | -28,438 | -22,872 |
| Free Cash Flow | -80,419 | -2,905 | 61,173 | -186,856 | -81,002 |